Alpha Tau Medical Statistics

Total Valuation

DRTS has a market cap or net worth of $146.57 million. The enterprise value is $78.06 million.

Market Cap	146.57M
Enterprise Value	78.06M

Important Dates

The next estimated earnings date is Monday, August 26, 2024, after market close.

Earnings Date	Aug 26, 2024
Ex-Dividend Date	n/a

Share Statistics

DRTS has 69.80 million shares outstanding. The number of shares has increased by 9.20% in one year.

Shares Outstanding	69.80M
Shares Change (YoY)	+9.20%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	25.67%
Owned by Institutions (%)	2.76%
Float	51.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.08, with a Debt / Equity ratio of 0.16.

Current Ratio	12.08
Quick Ratio	n/a
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.46

Financial Efficiency

Return on equity (ROE) is -31.90% and return on invested capital (ROIC) is -36.50%.

Return on Equity (ROE)	-31.90%
Return on Assets (ROA)	-26.40%
Return on Capital (ROIC)	-36.50%
Revenue Per Employee	n/a
Profits Per Employee	-$240,967
Employee Count	121
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DRTS has paid $16,000 in taxes.

Income Tax	16,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.28% in the last 52 weeks. The beta is 0.76, so DRTS's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-48.28%
50-Day Moving Average	2.39
200-Day Moving Average	2.89
Relative Strength Index (RSI)	40.50
Average Volume (20 Days)	51,948

Short Selling Information

The latest short interest is 28,313, so 0.04% of the outstanding shares have been sold short.

Short Interest	28,313
Short Previous Month	17,609
Short % of Shares Out	0.04%
Short % of Float	0.05%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.68M
Pretax Income	-29.14M
Net Income	-29.16M
EBITDA	-21.53M
EBIT	-22.60M
Earnings Per Share (EPS)	-$0.42

Full Income Statement

Balance Sheet

The company has $81.79 million in cash and $13.28 million in debt, giving a net cash position of $68.51 million or $0.98 per share.

Cash & Cash Equivalents	81.79M
Total Debt	13.28M
Net Cash	68.51M
Net Cash Per Share	$0.98
Equity (Book Value)	84.48M
Book Value Per Share	1.21
Working Capital	78.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.96 million and capital expenditures -$6.40 million, giving a free cash flow of -$24.36 million.

Operating Cash Flow	-17.96M
Capital Expenditures	-6.40M
Free Cash Flow	-24.36M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.20%
Shareholder Yield	-9.20%
Earnings Yield	-19.89%
FCF Yield	-16.62%

Analyst Forecast

The average price target for DRTS is $11.75, which is 459.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.75
Price Target Difference	459.52%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1